199 related articles for article (PubMed ID: 18504289)
1. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients.
Charlier C; Henegar C; Launay O; Pagnoux C; Berezné A; Bienvenu B; Cohen P; Mouthon L; Guillevin L
Ann Rheum Dis; 2009 May; 68(5):658-63. PubMed ID: 18504289
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population.
Takizawa Y; Inokuma S; Tanaka Y; Saito K; Atsumi T; Hirakata M; Kameda H; Hirohata S; Kondo H; Kumagai S; Tanaka Y
Rheumatology (Oxford); 2008 Sep; 47(9):1373-8. PubMed ID: 18577548
[TBL] [Abstract][Full Text] [Related]
3. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors during the course of primary small-vessel vasculitides.
Pavone L; Grasselli C; Chierici E; Maggiore U; Garini G; Ronda N; Manganelli P; Pesci A; Rioda WT; Tumiati B; Pavesi G; Vaglio A; Buzio C;
J Rheumatol; 2006 Jul; 33(7):1299-306. PubMed ID: 16783858
[TBL] [Abstract][Full Text] [Related]
8. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
9. Management and follow-up of localized Wegener's granulomatosis: a review of five cases.
Nishiike S; Kato T; Nagai M; Konishi M; Sakata Y
Acta Otolaryngol; 2004 Nov; 124(9):1103-8. PubMed ID: 15513558
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
Solans-Laqué R; Bosch-Gil J; Canela M; Lorente J; Pallisa E; Vilardell-Tarrés M
Lupus; 2008 Sep; 17(9):832-6. PubMed ID: 18755865
[TBL] [Abstract][Full Text] [Related]
11. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
12. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.
Reinhold-Keller E; Beuge N; Latza U; de Groot K; Rudert H; Nölle B; Heller M; Gross WL
Arthritis Rheum; 2000 May; 43(5):1021-32. PubMed ID: 10817555
[TBL] [Abstract][Full Text] [Related]
13. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
14. Difficulty of diagnosing Wegener's granulomatosis in the head and neck region.
Tsuzuki K; Fukazawa K; Takebayashi H; Hashimoto K; Sakagami M
Auris Nasus Larynx; 2009 Feb; 36(1):64-70. PubMed ID: 18479857
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.
Eriksson P; Jacobsson L; Lindell A; Nilsson JA; Skogh T
J Intern Med; 2009 Apr; 265(4):496-506. PubMed ID: 19141094
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.
Fardet L; Rybojad M; Gain M; Kettaneh A; Cherin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Dupuy A
Arch Dermatol; 2009 Aug; 145(8):889-93. PubMed ID: 19687419
[TBL] [Abstract][Full Text] [Related]
17. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients.
Bligny D; Mahr A; Toumelin PL; Mouthon L; Guillevin L
Arthritis Rheum; 2004 Feb; 51(1):83-91. PubMed ID: 14872460
[TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical characteristics of herpes zoster after lung transplantation.
Manuel O; Kumar D; Singer LG; Cobos I; Humar A
J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081
[TBL] [Abstract][Full Text] [Related]
19. Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.
Koening CL; Hernández-Rodríguez J; Molloy ES; Clark TM; Hoffman GS
J Rheumatol; 2009 Jan; 36(1):116-9. PubMed ID: 19012360
[TBL] [Abstract][Full Text] [Related]
20. Severe impaired respiratory ciliary function in Wegener granulomatosis.
Ullrich S; Gustke H; Lamprecht P; Gross WL; Schumacher U; Ambrosch P; Laudien M
Ann Rheum Dis; 2009 Jun; 68(6):1067-71. PubMed ID: 19028765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
